论文部分内容阅读
目的:探讨经腹与经胸腹联合2种路径行贲门癌手术的临床疗效。方法:168例贲门癌患者分为经胸切口手术组87例及胸腹联合切口手术组81例,对2组手术径路的疗效、术中出血量、术后并发症等指标进行观察分析。结果:2组手术淋巴结清扫数量、术后并发症发生率无明显差异(P>0.05),但手术时间、术中出血量、术后住院时间等方面2组存在较明显的差异(P<0.05)。结论:对于大多数病例,选择经胸贲门癌根治术要优于胸腹联合根治术。
Objective: To investigate the clinical effect of transabdominal and trans-thoracoabdominal combined with two kinds of pathways for cardia cancer surgery. Methods: A total of 168 patients with cardia cancer were divided into two groups: 87 cases in the operation of thoracic incision group and 81 cases in the operation group of thoracoabdominal incision. The curative effect, operative blood loss and postoperative complications of the two groups were observed and analyzed. Results: There was no significant difference in the number of lymph nodes dissection between the two groups and the incidence of postoperative complications (P> 0.05), but the operative time, intraoperative blood loss and postoperative hospital stay were significantly different (P <0.05 ). Conclusion: For the majority of cases, the choice of transthoracic cardiomyoplasty is better than thoracoabdominal combined radical mastectomy.